Fundraising Fox
David Kabakoff
InvestorExecutive Advisor, Private Equity at Sofinnova Ventures
Find your path to David
Sign up to see every warm intro you have to David
- Paths you didn't know you had: your email and LinkedIn already hold routes to David. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
David Kabakoff is a medicinal chemist with more than 30 years of experience leading technology and product development in the pharmaceutical, biopharmaceutical, and drug delivery fields. Before joining Sofinnova in 2007, he co-founded the cancer drug developer Salmedix, serving as Chairman and CEO until its acquisition by Cephalon, and previously held executive roles at Dura, Spiros Development, Corvas International, and Hybritech. He holds a PhD from Yale University and a BA from Case Western Reserve University.
Contact· self-published, not guessed
Invests in
Biotech
Deals · 1
RarecyteBoard seat
via Sofinnova Ventures · filed Jul 2023 · $35.7M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
AmplimmuneAntivaAntiva BiosciencesCastle BiosciencesInterMuneNeurana PharmaceuticalsNextCureNextCurePrincipiaTrius
Sources: the firm's website · SEC Form D filings.
Colleagues at Sofinnova Ventures
Frequently asked questions
- Who is David Kabakoff?
- David Kabakoff is a medicinal chemist with more than 30 years of experience leading technology and product development in the pharmaceutical, biopharmaceutical, and drug delivery fields. Before joining Sofinnova in 2007, he co-founded the cancer drug developer Salmedix, serving as Chairman and CEO until its acquisition by Cephalon, and previously held executive roles at Dura, Spiros Development, Corvas International, and Hybritech. He holds a PhD from Yale University and a BA from Case Western Reserve University.
- Where does David Kabakoff work?
- David Kabakoff is Executive Advisor, Private Equity at Sofinnova Ventures.
- What does David Kabakoff invest in?
- David Kabakoff invests in Biotech.
- What boards does David Kabakoff sit on?
- David Kabakoff holds tracked board seats at Amplimmune, Antiva, Antiva Biosciences, Castle Biosciences, InterMune, Neurana Pharmaceuticals, NextCure, NextCure, Principia, Rarecyte.
About this profile. Compiled from public sources — Sofinnova Ventures's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights